Development of artemisinin compounds for cancer treatment

HC Lai, NP Singh, T Sasaki - Investigational new drugs, 2013 - Springer
Artemisinin contains an endoperoxide moiety that can react with iron to form cytotoxic free
radicals. Cancer cells contain significantly more intracellular free iron than normal cells and …

Relevance of the deletion polymorphisms of the glutathione S-transferases GSTT1 and GSTM1 in pharmacology and toxicology

HM Bolt, R Thier - Current drug metabolism, 2006 - benthamdirect.com
Although cytosolic glutathione S-transferase (GST) enzymes occupy a key position in
biological detoxification processes, two of the most relevant human isoenzymes, GSTT1-1 …

Molecular pharmacology and pharmacogenomics of artemisinin and its derivatives in cancer cells

T Efferth - Current drug targets, 2006 - ingentaconnect.com
Secondary metabolites from plants can serve as defense against herbivores, microbes,
viruses or competing plants. Many compounds from medicinal plants have pharmacological …

Overview of tumor cell chemoresistance mechanisms

L Gatti, F Zunino - Chemosensitivity: Volume II: In VIVO Models, Imaging …, 2005 - Springer
Drug resistance of tumor cells is recognized as the primary cause of failure of
chemotherapeutic treatment of most human tumors. Although pharmacological factors …

Anticancer activities of artemisinin and its bioactive derivatives

GL Firestone, SN Sundar - Expert reviews in molecular medicine, 2009 - cambridge.org
Artemisinin, a sesquiterpene lactone derived from the sweet wormwood plant Artemisia
annua, and its bioactive derivatives exhibit potent anticancer effects in a variety of human …

Cytoprotective and regulatory functions of glutathione S-transferases in cancer cell proliferation and cell death

S Singh - Cancer chemotherapy and pharmacology, 2015 - Springer
Abstract Purpose Glutathione S-transferases (GSTs) family of enzymes is best known for
their cytoprotective role and their involvement in the development of anticancer drug …

Infection medications: Assessment in‐vitro glutathione S‐Transferase inhibition and molecular docking study

C Türkeş, Y Demir, Ş Beydemir - ChemistrySelect, 2021 - Wiley Online Library
Abstract Glutathione S‐transferases (EC 2.5. 1.18, GSTs), consisting of at least seven
subfamilies, such as alpha, kappa, mu, pi, theta, zeta, and omega, are the family of cytosolic …

Mechanistic perspectives for 1, 2, 4-trioxanes in anti-cancer therapy

T Efferth - Drug Resistance Updates, 2005 - Elsevier
In addition to their well-known anti-malarial activity, artemisinin and its derivatives (1, 2, 4-
trioxanes) possess potent activity against tumor cells in the nano-to micromolar range …

Dihydroartemisinin induces apoptosis in HL-60 leukemia cells dependent of iron and p38 mitogen-activated protein kinase activation but independent of reactive …

JJ Lu, LH Meng, YJ Cai, Q Chen, LJ Tong… - Cancer biology & …, 2008 - Taylor & Francis
Dihydroartemisinin (DHA), the main active metabolite of artemisinin derivatives, is one of the
most effective anti-malarial analogs of artemisinin. In the current study, we found that DHA …

The inhibition of human glutathione S-transferases activity by plant polyphenolic compounds ellagic acid and curcumin

R Hayeshi, I Mutingwende, W Mavengere… - Food and chemical …, 2007 - Elsevier
Glutathione S-transferases (GSTs) are multifunctional detoxification proteins that protect the
cell from electrophilic compounds. Overexpression of GSTs in cancer results in resistance to …